Picture of Janux Therapeutics logo

JANX — Janux Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Janux Therapeutics Posts Q3 Loss Per Share Of $0.26

Nov 9 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS REPORTS BUSINESS HIGHLIGHTS AND THIRD
QUARTER
2021 FINANCIAL RESULTS
    * JANUX THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.26

Source text for Eikon:  ID:nBw1NmG6Da 
Further company coverage:  JANX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Janux Therapeutics

See all news